Literature DB >> 20700811

Macular hole formation following photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide.

Daisuke Iwama, Sotaro Ooto, Akitaka Tsujikawa, Kenji Yamashiro, Nagahisa Yoshimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20700811     DOI: 10.1007/s10384-010-0819-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Macular hole following photodynamic therapy.

Authors:  Ahmad M Mansour; Ziad M Husseini; Alex R Schakal
Journal:  Ophthalmic Surg Lasers       Date:  2002 Nov-Dec

2.  Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

Authors:  F Gomi; M Sawa; H Sakaguchi; M Tsujikawa; Y Oshima; M Kamei; Y Tano
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

3.  Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Yumiko Kurashige; Atsushi Otani; Manabu Sasahara; Yuko Yodoi; Hiroshi Tamura; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2008-07-09       Impact factor: 5.258

4.  Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.

Authors:  Albert J Augustin; Stephan Puls; Indre Offermann
Journal:  Retina       Date:  2007-02       Impact factor: 4.256

5.  Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

Authors:  Richard F Spaide; John Sorenson; Leandro Maranan
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.